Neumora Therapeutics, Inc. (NMRA) Earnings
|
Expand Research on NMRA
| Next EPS Date | 8/12/26 | EPS Growth Rate | +18.2% |
|---|---|---|---|
| Average EPS % Beat Rate | +18.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -5.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | -$0.30 | -$0.30 | $0.00 | N/A | N/A | N/A |  | | Details | |
| 3/30/26 | Q425 | -$0.35 | -$0.47 | +$0.12 | N/A | N/A | N/A | | | Details | |
| 3/17/26 |
Q425 | N/A | -$0.47 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/16/26 |
Q425 | N/A | -$0.47 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/13/26 |
Q425 | N/A | -$0.47 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/11/26 |
Q425 | N/A | -$0.47 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 |
Q425 | N/A | -$0.45 | N/A | N/A | N/A | N/A | N/A | N/A |
